发明名称 |
Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist |
摘要 |
The present invention relates to methods for treating multiple sclerosis by administering therapeutically effective amounts of an alpha-fetoprotein polypeptide (or a biologically active fragment, derivative, or analog thereof) and an integrin antagonist (e.g., natalizumab) to a patient in need thereof. Also disclosed are compositions and kits that comprise therapeutically effective amounts of an alpha-fetoprotein polypeptide (or a biologically active fragment, derivative, or analog thereof) and an integrin antagonist (e.g., natalizumab). |
申请公布号 |
EP2510941(A2) |
申请公布日期 |
2012.10.17 |
申请号 |
EP20120171564 |
申请日期 |
2008.02.20 |
申请人 |
MERRIMACK PHARMACEUTICALS, INC. |
发明人 |
STEWART, EDWARD, J.;BRISKIN, MICHAEL |
分类号 |
A61K38/17;A61K39/395;C07K16/28 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|